Jill Lindley

Evaluation of the Bactericidal Activity of Fosfomycin in Combination with Selected Antimicrobial Comparison Agents Tested against Gram-Negative Bacterial Strains by Using Time-Kill Curves

Robert K. Flamm, Paul R. Rhomberg, Jill Lindley et al. · Antimicrobial Agents and Chemotherapy · 2019 · 48 citations · Full text

<i>In vitro</i> potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing <i>Enterobacterales</i>

Olga Lomovskaya, Mariana Castanheira, Jill Lindley et al. · Antimicrobial Agents and Chemotherapy · 2023 · 36 citations · Full text

<i>In Vitro</i> Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates

Michael D. Huband, Rodrigo E. Mendes, Michael A. Pfaller et al. · Antimicrobial Agents and Chemotherapy · 2020 · 28 citations · Full text

<i>In Vitro</i> Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa

Olga Lomovskaya, Debora Rubio-Aparicio, Kirk Nelson et al. · Antimicrobial Agents and Chemotherapy · 2021 · 26 citations · Full text

BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections

Shahul Hameed P, Harish Kaushik Kotakonda, Sreevalli Sharma et al. · Nature Communications · 2024 · 14 citations · Full text